HSP90AA1 and myeloproliferative disorder: Furthermore, combined treatment that included HSP90 inhibitors and JAK2 inhibitors induced a greater depletion of the signaling proteins than a single inhibitor alone, and synergistically induced apoptosis in human primary CD34(+) MPN cells harboring JAK2V617F [50].